About 30 percent of men experience an AUA symptoms index improvement of 3 or more points.
Improvements observed in urinary symptoms and bone mineral density.
Men with a body mass index of 30 kg/m2 or higher had a 39.3% prevalence of low testosterone, study finds.
Significant declines in International Prostate Symptom Score observed, regardless of whether or not men lost weight or used a phosphodiesterase-5 inhibitor.
Desmopressin appears to reduce nocturia and other LUTS while also significantly increasing testosterone levels in late-onset hypogonadism.
Study results underscore the need for additional research to find other surrogate markers of urinary infection.
Lower urinary tract symptoms actually improved in many men, with minimal change in PSA level.
Lower urinary tract symptoms (LUTS) are commonly attributed to benign prostatic hyperplasia.
Saw palmetto remains the most common herbal treatment for men with LUTS.
Orange or grapefruit juice consumption may be protective in men, study finds.
Highest intake was associated with a 46% decreased progression risk compared with the lowest intake.
Many men even experience an improvement in lower urinary tract symptoms.
Tadalafil plus finasteride improved symptoms scores better than finasteride plus placebo.
Lower urinary tract symptoms alone should raise suspicion for the malignancy.
Following surgery, symptom severity declined significantly and remained stable over 10 years.
Alpha blockers are the mostly commonly prescribed drugs to treat LUTS secondary to BPH.
If patients are not bothered by symptoms, they do not necessarily require treatment, Australian researcher says.
Treatment of LUTS secondary to BPH has evolved from surgical therapy to medical monotherapy, and now combination therapy.
Small study is the first prospective investigation of this procedure in the U.S.
A new study has found that tadalafil co-administered with finasteride significantly improved scores in men with lower urinary tract symptoms.
The procedure may be particularly useful in treatment men with prostates larger than 100 cc.
Outcomes similar to HoLEP-treated patients who did not have prior surgery.
Study points to increased diagnostic intensity among men whose lower urinary tract symptoms come to physicians' attention.
Study reveals no significant difference in operative or postoperative complications in patients with and without prior surgery.
Researchers report that men with waists measuring 100 cm or more are up to three times more likely to have LUTS.
Men with a waist circumference of 100 cm or greater were more likely to have eight or more voids per 24 hours than men with smaller waists.
Healthy eating may lower the risk of lower urinary tract symptoms (LUTS), according to data presented at the American Urological Association 2012 annual meeting.
Recent use of nonsteroidal anti-inflammatory agents (NSAIDs) do not protect against development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), a new study concluded.
QUEBEC CITY—Evaluation of lower urinary tract symptoms (LUTS) using validated questionnaires prior to renal transplantation (Tx) may predict which patients will experience significant LUTS after transplantation, researchers reported at the Canadian Society of Transplantation annual meeting.
Use of a prostatic urethral lift procedure, a minimally invasive treatment for lower urinary tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH), preserves sexual function, according to a study published online ahead of print in The Journal of Sexual Medicine.